Graduation or Premature Exit? The Fight Over TAVR’s Evidence Mandate
One of the most closely watched elements of CMS’s 2026 proposal concerns whether Medicare should continue requiring evidence collection for TAVR. Ending coverage with evidence development (CED) for symptomatic patients…




